Table 1 Characteristics of patients and lesions
Characteristic | Value |
|---|---|
Age | |
Median (IQR), years | 73 (69–79) |
Sex | |
Male/female | 98/25 |
Oral antithrombotic agents, n (%) | |
None | 95 (77.2) |
Warfarin | 3 (2.4) |
DOAC | 3 (2.4) |
DAPT | 1 (0.8) |
Clopidogrel | 3 (2.4) |
Aspirin | 7 (5.7) |
Aspirin + others | 1 (0.8) |
Cilostazol | 2 (1.6) |
Others | 8 (6.5) |
Dialysis, n (%) | 2 (1.6) |
Heparin replacement, n (%) | 1 (0.8) |
Lesion site, n (%) | |
Upper | 16 (13.0) |
Middle | 59 (48.0) |
Lower | 48 (39.0) |
Length of resected specimen | |
Median (IQR), cm | 3.0 (2.5–4.1) |
Resection area | |
Median (IQR), cm2 | 5.5 (3.5–9.4) |
Length of tumor | |
Median (IQR), cm | 1.3 (0.7–2.0) |
Pathological diagnosis, n (%) | |
Adenocarcinoma | 106 (86.2) |
Adenoma | 14 (11.4) |
Others | 3 (2.4) |
Depth, n (%) | |
Intramucosa | 99 (80.5) |
Submucosa | 24 (19.5) |
Macroscopic type, n (%) | |
Depressed | 52 (42.3) |
Nondepressed | 71 (57.7) |
Submucosal fibrosis, n (%) | |
Negative | 107 (87.0) |
Positive | 16 (13.0) |
Blood type, n (%) | |
O | 40 (32.5) |
A | 37 (30.1) |
B | 35 (28.5) |
AB | 11 (8.9) |